ElevateBio’s Post

We’re honored to be ranked #8 on CNBC's #Disruptor50 list, marking our third recognition in four years. It’s a privilege to advance the future of cell and gene therapy. Hear what being a disruptor means to Emyline (Emmy) Lumasag, our People Experience Specialist II:

We are leveraging artificial intelligence (AI) to accelerate the discovery and design of CRISPR systems to propel us closer to our promise of developing therapeutic options for patients in need. #AI #ElevateBio #CRISPR

We're excited to share the progress of ElevateBio’s new BaseCamp Pittsburgh biomanufacturing facility built in partnership with the University of Pittsburgh and the Richard King Mellon Foundation. Discover how BaseCamp Pittsburgh will bring technologies, expertise, operations, processes, manufacturing, and workforce development to a city ready to participate in this growing life sciences industry and be a part of the development and commercialization of transformative therapies.

Congratulations to our partner Abata Therapeutics on this terrific achievement!  We’re proud to work with Abata, leveraging our manufacturing and process development capabilities at BaseCamp and our LentiPeak™ lentiviral vector technology platform to advance this program and bring potentially transformative therapies to patients in need.

We're excited to welcome our 2024 Summer Intern & Co-Op class! Hear what a few of our innovators look forward to learning at ElevateBio and Life Edit Therapeutics. We’re proud to mentor and educate students in transforming the future of medicine. #ElevateBio #Internship #CellAndGeneTherapy

An efficient technology transfer is vital to the production and development of genetic medicines. By partnering with us at ElevateBio, you’re ensuring a fast, consistent, and cost-effective technology integration of knowledge, processes, specifications, and data into BaseCamp. Learn how we can help accelerate production and safeguard your timelines: https://lnkd.in/gxPGzREJ. #ElevateBio #GeneTherapy

Today, we celebrate freedom–to innovate, to explore, and to embark on our culture of expedition toward groundbreaking therapies. Have a safe and happy Independence Day! #4thOfJuly

We'll be presenting at the Global Cell & Gene Therapy Summit in Boston! Join Supriya Prakash, Ph.D., Scientist I, Cellular Process Development, for "Low Volume Wash, Formulation and Fill Strategies for T Cell Therapies" (CGT-7) on July 9. For additional details, visit https://cgtsummit.com/. We look forward to networking with you! #CellAndGeneTherapy

Our novel lipid nanoparticles (LNP) platform has both liver targeting and de-targeting potential, enhancing our ability to effectively deliver gene therapies and unlocking new possibilities for addressing a wide range of diseases and disorders. Discover our platform’s potential and delivery capabilities at https://lnkd.in/e8PRHJnj. #ElevateBio #GeneEditing

Pride Month is a time to celebrate the LGBTQ+ community and equality. At our 2nd Annual Smith Street Pride Party, co-hosted with Boston Dynamics and Deciphera Pharmaceuticals. Our teammates enjoyed various activities, including a raffle benefiting The Trevor Project, a leading nonprofit for LGBTQ youth suicide prevention. At ElevateBio, diversity, equity, and inclusion are fundamental to our values. "Respect Perspective" highlights the importance of honoring each teammate's unique voice and experience. #ElevateBio #Pride